Release Date: 30/01/12 16:43 Summary: Quarterly Activities and Cashflow Report Price Sensitive: Yes Download Document 2.03MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%